跳至主要内容
临床试验/ACTRN12622000526774
ACTRN12622000526774招募中未知

Efficacy of repeated low-level red-light therapy in myopia control in schoolchildren: a randomized controlled trial

Eyerising International Pty Ltd0 个研究点目标入组 108 人开始时间: 2022年4月4日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
8 Years 至 13 Years(—)
性别
All

入选标准

  • 1) Provision of consent
  • 2) Age: >=8 and <= 13 years at enrolment
  • 3) Myopia: Spherical equivalent refractions (SERs) under cycloplegia: -1.00 to -5.00 diopters (D)
  • 4) Astigmatism of 2.50 D or less
  • 5) Anisometropia of 1.50 D or less
  • 6) Corrected monocular logMAR visual acuity (VA): 1.0 or better
  • 7) Consent to participate in random allocation of grouping
  • 8) Fluent in English
  • 9) Willing and able to participate in all required activities of the study

排除标准

  • 1) Strabismus and binocular vision abnormalities in either eye
  • 2) Ocular abnormalities in either eye or other systemic abnormalities that affect participate in all required activities of the study.
  • 3) Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc.
  • 4) Other reasons, including but not limited to severe physical and cognitive disability, that the physician may consider inappropriate for enrolment
  • 5) Noncompliance with treatment
  • 6) Children whose parents do not sign informed consent

研究者

发起方
Eyerising International Pty Ltd

相似试验

Efficacy of repeated low-level red-light therapy in... | 临床试验